Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lucas

Showing results (1151-1160 of 1,357) with videos related to

Pageof 136
Sort By:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 30, 2016
IDENTIFYING GENETIC ASSOCIATIONS WITH VARIABILITY IN METABOLIC HEALTH AND BLOOD COUNT LABORATORY VALUES: DIVING INTO THE QUANTITATIVE TRAITS BY LEVERAGING LONGITUDINAL DATA FROM AN EHRShefali S Verma, Anastasia M Lucas, Daniel R Lavage, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
American Journal of Epidemiology|April 16, 2013
Occupational exposure and risk of central nervous system demyelinationP C Valery, R M Lucas, D B Williams, et al.
Mabs|January 5, 2010
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphomaLapo Alinari, Valerie L White, Christian T Earl, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Multiple Sclerosis and Related Disorders|November 11, 2019
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic reviewWolfgang Marx, Meghan Hockey, Amelia J McGuinness, et al.
Neurology|March 10, 2012
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune StudyA-L Ponsonby, R M Lucas, I A van der Mei, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Frontiers in Immunology|July 31, 2018
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated SyndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.
Clinical and Experimental Immunology|April 23, 2013
Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentiallyA-M Hughes, R M Lucas, A J McMichael, et al.
Pageof 136

Showing results (1151-1160 of 1,357) with videos related to

Sort By:
Pageof 136
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 30, 2016
IDENTIFYING GENETIC ASSOCIATIONS WITH VARIABILITY IN METABOLIC HEALTH AND BLOOD COUNT LABORATORY VALUES: DIVING INTO THE QUANTITATIVE TRAITS BY LEVERAGING LONGITUDINAL DATA FROM AN EHRShefali S Verma, Anastasia M Lucas, Daniel R Lavage, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
American Journal of Epidemiology|April 16, 2013
Occupational exposure and risk of central nervous system demyelinationP C Valery, R M Lucas, D B Williams, et al.
Mabs|January 5, 2010
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphomaLapo Alinari, Valerie L White, Christian T Earl, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Multiple Sclerosis and Related Disorders|November 11, 2019
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic reviewWolfgang Marx, Meghan Hockey, Amelia J McGuinness, et al.
Neurology|March 10, 2012
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune StudyA-L Ponsonby, R M Lucas, I A van der Mei, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Frontiers in Immunology|July 31, 2018
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated SyndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.
Clinical and Experimental Immunology|April 23, 2013
Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentiallyA-M Hughes, R M Lucas, A J McMichael, et al.
Pageof 136